F-SCOPE, a quantitative 13C/15N labeling analysis, provides new aspect of metabolic changes in your research. Based on the unique CE-MS technology and wealth of experiences, HMT promises your best approach to the labeling analysis.
Human Metabolome Technologies (HMT) is a Japan-based biotechnology company developing capillary electrophoresis mass spectrometry (CE-MS) based metabolomics technologies and solution to drive drug discovery, diagnosis, and food production. Our research and development methodology are at the heart of an emerging field of metabolomics and systems biology.
Human Metabolome Technologies, Inc. (HMT), the leading developer of capillary electrophoresis mass spectrometry (CE-MS) based metabolomics, released an analysis service offering cancer metabolism profiling, CARCINOSCOPE.